WO2003035895A3 - Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample - Google Patents
Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample Download PDFInfo
- Publication number
- WO2003035895A3 WO2003035895A3 PCT/US2002/034570 US0234570W WO03035895A3 WO 2003035895 A3 WO2003035895 A3 WO 2003035895A3 US 0234570 W US0234570 W US 0234570W WO 03035895 A3 WO03035895 A3 WO 03035895A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- rare
- detection
- assay
- blood
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Dentistry (AREA)
- Hospice & Palliative Care (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002465288A CA2465288A1 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
EP02795565A EP1438419A2 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
KR10-2004-7006181A KR20040047971A (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
IL16135702A IL161357A0 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
JP2003538395A JP2005507997A (en) | 2001-10-26 | 2002-10-28 | Multi-parameter analysis of comprehensive nucleic acid and morphological features for the same sample |
BRPI0213520-5A BR0213520A (en) | 2001-10-26 | 2002-10-28 | method for diagnosing the severity of a disease in a test subject; and, testing kit for screening a patient sample for the presence of circulating cancer cells. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33066901P | 2001-10-26 | 2001-10-26 | |
US60/330,669 | 2001-10-26 | ||
US36994502P | 2002-04-04 | 2002-04-04 | |
US60/369,945 | 2002-04-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003035895A2 WO2003035895A2 (en) | 2003-05-01 |
WO2003035895A3 true WO2003035895A3 (en) | 2004-01-08 |
Family
ID=26987390
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034397 WO2003035894A2 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
PCT/US2002/034570 WO2003035895A2 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034397 WO2003035894A2 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1438419A2 (en) |
JP (1) | JP2005507997A (en) |
KR (1) | KR20040047971A (en) |
CN (1) | CN1610752A (en) |
AU (1) | AU2002360305A1 (en) |
BR (1) | BR0213520A (en) |
CA (2) | CA2465288A1 (en) |
IL (1) | IL161357A0 (en) |
WO (2) | WO2003035894A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913697B2 (en) | 2001-02-14 | 2005-07-05 | Science & Technology Corporation @ Unm | Nanostructured separation and analysis devices for biological membranes |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
AU2003216175A1 (en) | 2002-02-04 | 2003-09-02 | Colorado School Of Mines | Laminar flow-based separations of colloidal and cellular particles |
US20050095634A1 (en) * | 2003-10-16 | 2005-05-05 | Genomic Health Inc. | qRT-PCR assay system for gene expression profiling |
US7332597B2 (en) | 2004-06-28 | 2008-02-19 | University Of Kentucky Research Foundation | Primers and probe to identify mycobacterium tuberculosis complex |
ITBO20040420A1 (en) | 2004-07-07 | 2004-10-07 | Type S R L | METAL CUTTING AND FORMING MACHINE |
DE102005013261A1 (en) * | 2005-03-22 | 2006-09-28 | Adnagen Ag | Reagent and method for preventing time-dependent expression in biological cells |
DE102005029808A1 (en) * | 2005-06-27 | 2007-01-04 | Siemens Ag | Support material, process for its preparation and use |
ITBO20050481A1 (en) | 2005-07-19 | 2007-01-20 | Silicon Biosystems S R L | METHOD AND APPARATUS FOR THE HANDLING AND / OR IDENTIFICATION OF PARTICLES |
US20100152055A1 (en) | 2005-09-02 | 2010-06-17 | Satoko Kozono | Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
US20070059683A1 (en) * | 2005-09-15 | 2007-03-15 | Tom Barber | Veterinary diagnostic system |
CA2623405C (en) * | 2005-09-20 | 2014-11-25 | Immunivest Corporation | Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes |
US9134237B2 (en) | 2005-09-20 | 2015-09-15 | Janssen Diagnotics, LLC | High sensitivity multiparameter method for rare event analysis in a biological sample |
ITBO20050646A1 (en) | 2005-10-26 | 2007-04-27 | Silicon Biosystem S R L | METHOD AND APPARATUS FOR CHARACTERIZATION AND COUNTING OF PARTICLES |
US8119976B2 (en) | 2007-07-03 | 2012-02-21 | Colorado School Of Mines | Optical-based cell deformability |
US9487812B2 (en) | 2012-02-17 | 2016-11-08 | Colorado School Of Mines | Optical alignment deformation spectroscopy |
US9878326B2 (en) | 2007-09-26 | 2018-01-30 | Colorado School Of Mines | Fiber-focused diode-bar optical trapping for microfluidic manipulation |
US9885644B2 (en) | 2006-01-10 | 2018-02-06 | Colorado School Of Mines | Dynamic viscoelasticity as a rapid single-cell biomarker |
ITTO20060226A1 (en) | 2006-03-27 | 2007-09-28 | Silicon Biosystem S P A | METHOD AND APPARATUS FOR PROCESSING AND OR ANALYSIS AND OR SELECTION OF PARTICLES, IN PARTICULAR BIOLOGICAL PARTICLES |
CA2647843A1 (en) * | 2006-04-18 | 2007-10-25 | Wellstat Biologics Corporation | Detection of proteins from circulating neoplastic cells |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
CN101583722A (en) | 2006-07-14 | 2009-11-18 | 阿维瓦生物科学股份有限公司 | Methods and compositions for detecting rare cells from a biological sample |
JP4926812B2 (en) * | 2007-02-01 | 2012-05-09 | シスメックス株式会社 | Blood cell analyzer and body fluid analysis method |
US10722250B2 (en) | 2007-09-04 | 2020-07-28 | Colorado School Of Mines | Magnetic-field driven colloidal microbots, methods for forming and using the same |
ITTO20070771A1 (en) | 2007-10-29 | 2009-04-30 | Silicon Biosystems Spa | METHOD AND APPARATUS FOR IDENTIFICATION AND HANDLING OF PARTICLES |
IT1391619B1 (en) * | 2008-11-04 | 2012-01-11 | Silicon Biosystems Spa | METHOD FOR THE IDENTIFICATION, SELECTION AND ANALYSIS OF TUMOR CELLS |
US10895575B2 (en) | 2008-11-04 | 2021-01-19 | Menarini Silicon Biosystems S.P.A. | Method for identification, selection and analysis of tumour cells |
SG174459A1 (en) | 2009-03-17 | 2011-10-28 | Silicon Biosystems Spa | Microfluidic device for isolation of cells |
JP5729904B2 (en) | 2009-06-02 | 2015-06-03 | キヤノン株式会社 | Methods for preparing proteins, DNA, RNA from cells |
JP5686098B2 (en) * | 2009-09-17 | 2015-03-18 | Jsr株式会社 | Dissociation method and dissociator for avidin and biotin derivative |
EP2521778B1 (en) * | 2010-01-04 | 2014-03-19 | QIAGEN Gaithersburg, Inc. | Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples |
WO2012034013A2 (en) | 2010-09-10 | 2012-03-15 | Bio-Rad Laboratories, Inc. | Detection of rna-interacting regions in dna |
CN102565404B (en) * | 2010-12-24 | 2014-04-16 | 牛刚 | Kit for detecting free colorectal cancer cell markers in blood |
CN102156164B (en) * | 2011-01-13 | 2012-12-12 | 北京肿瘤医院 | Mass spectra identification method of nucleophosmin variable spliceosome and gastric cancer diagnostic reagent kit |
CN102109525B (en) * | 2011-01-26 | 2013-10-16 | 牛刚 | Kit for detecting free breast cancer cell marker in blood |
US20120208193A1 (en) | 2011-02-15 | 2012-08-16 | Bio-Rad Laboratories, Inc. | Detecting methylation in a subpopulation of genomic dna |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
CN107400711A (en) * | 2011-08-03 | 2017-11-28 | 伯乐实验室公司 | Use the cell filtration small nucleic acids being permeabilized |
ITTO20110990A1 (en) | 2011-10-28 | 2013-04-29 | Silicon Biosystems Spa | METHOD AND APPARATUS FOR OPTICAL ANALYSIS OF LOW TEMPERATURE PARTICLES |
ITBO20110766A1 (en) | 2011-12-28 | 2013-06-29 | Silicon Biosystems Spa | DEVICES, EQUIPMENT, KITS AND METHOD FOR THE TREATMENT OF A BIOLOGICAL SAMPLE |
WO2014067528A1 (en) * | 2012-10-29 | 2014-05-08 | Arcedi Biotech Aps | Improved enrichment and detection of rare blood cells |
US9857361B2 (en) | 2013-03-15 | 2018-01-02 | Iris International, Inc. | Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples |
BR112015023425B1 (en) | 2013-03-15 | 2021-01-12 | Iris International, Inc. | method and composition for staining and processing a urine sample |
US9771571B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
US9771572B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
USRE48665E1 (en) * | 2014-02-28 | 2021-08-03 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
JP2014158468A (en) * | 2014-03-05 | 2014-09-04 | Clinical Genomics Pty Ltd | Detection method |
RU2761432C2 (en) * | 2015-02-10 | 2021-12-08 | Иллюмина, Инк. | Method and composition for analysis of cellular components |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
US10282588B2 (en) * | 2016-06-09 | 2019-05-07 | Siemens Healthcare Gmbh | Image-based tumor phenotyping with machine learning from synthetic data |
CN110456034B (en) * | 2018-05-07 | 2022-07-22 | 上海市第十人民医院 | Detection method of circulating tumor cells |
CN109402240B (en) * | 2019-01-08 | 2020-08-25 | 圣湘生物科技股份有限公司 | Nucleic acid releasing agent, nucleic acid PCR amplification method and PCR amplification kit |
WO2023080601A1 (en) * | 2021-11-05 | 2023-05-11 | 고려대학교 세종산학협력단 | Disease diagnosis method and device using machine learning-based lens-free shadow imaging technology |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882864A (en) * | 1995-07-31 | 1999-03-16 | Urocor Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US6156515A (en) * | 1999-02-09 | 2000-12-05 | Urocor, Inc. | Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929556A (en) * | 1986-02-06 | 1990-05-29 | The Dow Chemical Company | Enzyme immobilization with polysulfonium salts |
US5346994A (en) * | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
PT938320E (en) * | 1996-03-26 | 2010-09-22 | Michael S Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
US6156564A (en) * | 1996-06-07 | 2000-12-05 | The United States Of America As Represented By The Department Of Health And Human Services | Cellular apoptosis susceptibility protein (CSP) and antisense CSP |
JP2002503814A (en) * | 1998-02-12 | 2002-02-05 | イムニベスト・コーポレイション | Methods and reagents for rapid and efficient isolation of circulating cancer cells |
US6358697B2 (en) * | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
-
2002
- 2002-10-28 BR BRPI0213520-5A patent/BR0213520A/en unknown
- 2002-10-28 CA CA002465288A patent/CA2465288A1/en not_active Abandoned
- 2002-10-28 CN CNA028261313A patent/CN1610752A/en active Pending
- 2002-10-28 KR KR10-2004-7006181A patent/KR20040047971A/en not_active Application Discontinuation
- 2002-10-28 CA CA002465274A patent/CA2465274A1/en not_active Abandoned
- 2002-10-28 EP EP02795565A patent/EP1438419A2/en not_active Withdrawn
- 2002-10-28 IL IL16135702A patent/IL161357A0/en unknown
- 2002-10-28 EP EP02795554A patent/EP1438398A2/en not_active Withdrawn
- 2002-10-28 WO PCT/US2002/034397 patent/WO2003035894A2/en not_active Application Discontinuation
- 2002-10-28 JP JP2003538395A patent/JP2005507997A/en not_active Ceased
- 2002-10-28 WO PCT/US2002/034570 patent/WO2003035895A2/en not_active Application Discontinuation
- 2002-10-28 AU AU2002360305A patent/AU2002360305A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882864A (en) * | 1995-07-31 | 1999-03-16 | Urocor Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US6156515A (en) * | 1999-02-09 | 2000-12-05 | Urocor, Inc. | Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
Also Published As
Publication number | Publication date |
---|---|
JP2005507997A (en) | 2005-03-24 |
CA2465288A1 (en) | 2003-05-01 |
WO2003035894A3 (en) | 2003-12-04 |
WO2003035895A2 (en) | 2003-05-01 |
IL161357A0 (en) | 2004-09-27 |
CA2465274A1 (en) | 2003-05-01 |
CN1610752A (en) | 2005-04-27 |
EP1438398A2 (en) | 2004-07-21 |
BR0213520A (en) | 2006-05-23 |
WO2003035894A2 (en) | 2003-05-01 |
EP1438419A2 (en) | 2004-07-21 |
AU2002360305A1 (en) | 2003-05-06 |
KR20040047971A (en) | 2004-06-05 |
WO2003035894A8 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003035895A3 (en) | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample | |
Goidin et al. | Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and β-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations | |
Keilholz et al. | Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group | |
AU767983B2 (en) | Methods for detecting nucleic acids indicative of cancer | |
WO2005098046A3 (en) | Methods for the determination of cell specific biomarkers | |
CA2455731A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
CA2435917A1 (en) | Highly sensitive method for the detection of cytosine methylation patterns | |
EP2357255A2 (en) | Assay for methylation in the GST-Pi gene | |
JP2003508083A (en) | Methods for disease detection | |
EP2977467B1 (en) | Method, use of marker, and determination device for obtaining information on plural types of cancers | |
US20200123613A1 (en) | Compositions and methods for diagnosing lung cancers using gene expression profiles | |
CN107475388B (en) | Application of nasopharyngeal carcinoma related miRNA as biomarker and nasopharyngeal carcinoma detection kit | |
JP2023109998A (en) | Detection of microsatellite instability | |
NO20032697L (en) | Test strip assay system and assay method for detection and / or determination of specific nucleic acid sequences | |
CA2462932A1 (en) | Method for the detection of cytosine methylations in immobilized dna samples | |
CA2382848A1 (en) | Diagnostics and therapeutics for osteoporosis | |
WO1996021042A3 (en) | Primers for the pcr amplification of metastatic sequences | |
CN100371459C (en) | Kit with fluorescent quantitative RT-PCR detection technique used for cell keratin 19(Ck19)mRNA | |
US20080286784A1 (en) | Method for Detection of DNA Methyltransferase RNA in Plasma and Serum | |
CN116219020B (en) | Methylation reference gene and application thereof | |
US20040029117A1 (en) | Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA | |
Krstulovic et al. | High performance liquid chromatographic determination of serum UV profiles of normal subjects and patients with breast cancer and benign fibrocystic changes | |
Max et al. | Nested quantitative real time PCR for detection of occult tumor cells | |
WO2014046199A1 (en) | Method for obtaining information about brain tumor and marker and kit for obtaining information about brain tumor | |
US8043835B1 (en) | Methods for detecting and monitoring cancer using extracellular RNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 161357 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002795565 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003538395 Country of ref document: JP Ref document number: 2465288 Country of ref document: CA Ref document number: 1020047006181 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002360316 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028261313 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002795565 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002795565 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0213520 Country of ref document: BR |